Kalvista Pharmaceuticals
Price & Volume
Stats
See more52W Range | $9.83-$21.30 |
Market Cap | $1B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $73.6M |
Revenue Growth (YoY) | 30.7% |
Gross Profit (12 Mos) | $18.9M |
Diluted EPS | -$3.94 |
News
See moreYahoo Finance • 2 days ago
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
Yahoo Finance • 6 days ago
Most and least shorted small-to-mid-cap stocks
Yahoo Finance • 18 days ago
KalVista Pharmaceuticals Q4 Earnings Call Highlights
Yahoo Finance • 24 days ago
Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools
About
CEO | Mr. Benjamin L. Palleiko |
Address | 200 Crossing Boulevard, Framingham, MA, United States, 01702 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 275 |
